1. Canopy Growth Corporation Reports Third Quarter Fiscal 2019 Financial Results:
  2. Treating Yourself Relaunches Medical Cannabis Website
  3. Sunniva Announces Completion of $15 Million Convertible Debenture Financing
  4. Supreme Cannabis Announces Q2 2019 Financial Results
  5. ‘This is the new Vitamin C’: Biome Grow to sign major CBD source deal
  6. Could Cannabis Cosmeceuticals be the Next Billion Dollar Idea?
  7. Biome Grow announces Memorandum of Understanding to purchase up to 20,000 kg per year of hemp-grown CBD extract from industrial hemp grower CBD Acres
  8. Aurora Releases Q2 Financial Results
  9. O’Cannabiz Toronto Expo, Conference & Industry Awards April 25-27 2019
  10. Biome Grow announces first shipment of finished product to Newfoundland and Labrador
  11. Supreme Cannabis Expands Domestic Distribution to Eight Provinces
  12. 48North Closes its $10 million Private Placement
  13. Aphria’s Board of Directors Rejects Green Growth Brand’s Hostile Takeover Bid
  14. Planet 13 Announces Customer Traffic for January 2019
  15. iAnthus and MPX Bioceutical Announce Closing of $1.6 Billion Business Combination
  16. Namaste Board Launches Strategic Review Process; Announces Termination of CEO Sean Dollinger and Commences Legal Action
  17. World Health Organization Recommends Rescheduling Marijuana Under International Treaties
  18. What Drove Altria’s Revenue in the Fourth Quarter?
  19. Surprise! Tilray’s CEO Just Dumped $11 Million in Stock
  20. Origin House Signs Exclusive Distribution Agreement and Provides Strategic Financing to Utopia Cannabis
  21. Slang, a Canopy Growth-backed Cannabis Company on CSE, off to Half-Billion Dollar Valuation
  22. PharmaCielo Establishes Joint Venture with Mino Labs to Bring Medicinal Cannabis Oil to Mexico
  23. Origin House Signs Exclusive Agreement with Viola Brands for California
  24. TGOD Completes Knud Jepsen Agreement
  25. Green Growth Brands Files Offer to Purchase and Circular for Aphria Inc.; Aphria Urges Shareholders to “Take No Action”
  26. MPX Receives Final Court Approval for Arrangement with iAnthus
  27. Invictus MD Announces Submission Of Its Application To List On NASDAQ And Share Consolidation
  28. HEXO to Begin Trading on the NYSE American, Announces Results of AGM
  29. Nova Scotia’s Highland Grow Secures Second Purchase Order with the NSLC
  30. MPX Securityholders Approve Business Combination with iAnthus
  31. Invictus and GTEC Holdings Announce Formal Termination Of Merger Plans
  32. Biome Opens the Door to U.S. Investors
  33. Aleafia Fulfills First Transaction Under Cannabis Supply Agreement with CannTrust
  34. Aurora to Acquire Whistler
  35. Aphria Releases Q2 Results as Founders Step Down
  36. Curaleaf Set To Expand Operations In Maryland With New Financing And Purchase Option Agreements
  37. PharmaCielo Announces TSX Venture Listing and Provides Corporate Update
  38. Emerald Health Closes Emerald Health Naturals Joint Venture
  39. Biome Grow subsidiary, Highland Grow secures purchase order with NSLC and sends first shipment of finished product
  40. SUPREME CANNABIS RECEIVES CONDITIONAL APPROVAL TO LIST ON THE TORONTO STOCK EXCHANGE
  41. KUSHCO HOLDINGS REPORTS FIRST FISCAL QUARTER 2019 RESULTS
  42. Aurora Cannabis Provides Guidance for the Second Quarter of Fiscal 2019, Anticipating Net Revenues of $50M to $55M
  43. Curaleaf Launches Its 20th Medical Marijuana Dispensary in Florida
  44. iAnthus Opens Flagship Citiva Dispensary in Brooklyn
  45. TGOD Signs a Commercial Sublicense with EnWave and Tilray to Dry Cannabis in Canada
  46. The Fastest-Growing Marijuana Stocks in 2019
  47. Biome Announces OTCQB Listing
  48. Green Growth Brands Launches Hostile Takeover Bid for Aphria Inc.
  49. Cannabis Stocks Mixed on Monday
  50. Health Canada Announces Proposed Regulations for Cannabis Edibles, Extracts, and Topicals
  51. Northland Capital Initiates Coverage on Planet 13 Holdings
  52. Details on Ontario’s New Private Cannabis Retail Lottery
  53. GrowHealthy Opens First Flagship Dispensary in Florida, With Plans for Two More by End of 2018
  54. Biome Grow Receives Amended Health Canada Sales License for its Nova Scotia-based Highland Grow.
  55. Canada’s Largest Province To Approve Only 25 Store Licences Due to Supply Shortage
  56. The Next Cannabis Wave? A $3.7 Trillion Wellness Market
  57. Canopy Growth announces multi-year extraction agreement with Valens GroWorks
  58. Here’s Why Marijuana Stocks Deserve Coal in Their Stockings This Year
  59. Biome Receives DTC Eligibility in United States, OTC symbol “ORTFF”
  60. U.S. House of Representatives Passes the Farm Bill
  61. Mississauga and Markham Opt-Out of Cannabis Retail Stores
  62. Interview with Diane Scott, Chairman and Chief Executive Officer, Jamaican Medical Cannabis Corporation (JMCC)
  63. Canada’s Aurora Cannabis buys Mexico’s Farmacias Magistrales
  64. Altria Moves into the Herd
  65. Cronos group inc. Announces c$2.4 billion strategic investment from altria group, inc
  66. Canopy Acquires Storz & Bickel
  67. CANNABIS MEETS HEALTHCARE
  68. Aphria Shares Down this Morning
  69. 48North Has Two Major Announcements
  70. Cannabis stock report: Congress agrees on new farm bill legislation, CBD industry readies to explode
  71. Cannabis Daily’s Top 35 Stocks Now Updated
  72. iAnthus Announces Third Quarter 2018 Financial Results
  73. Green Thumb Industries (GTI) Announces Year-over-Year Revenue Growth of 344% and Sequential Revenue Growth of 26% for Third Quarter 2018
  74. 48North Cannabis Corp. Announces Revenue Growth for Fiscal Q1 2019
  75. KUSHCO HOLDINGS REPORTS FISCAL YEAR 2018 RESULTS
  76. Canada’s Grand Cannabis Experiment Has Set Scientists Free
  77. What Did Canadian Cannabis Legalization Do to the Stock Markets?
  78. Cannabis 3.0?
  79. Cannabis firms spent millions marketing their pot last quarter – did it work?
  80. Biome Grow, Now Publicly Traded but Falling Under the Radar
  81. John Boehner-Backed Pot Firm Sees This Boosting U.S. Weed Listings
  82. MJBizCon Las Vegas Redefines Scale in Cannabis Trade Shows
  83. Ontario Establishes Strict Regulations for the Licensing and Operation of Private Cannabis Stores
  84. Canopy Growth Losses Widen Sharply, But Cannabis Sales Prices Spike
  85. Biome Grow subsidiary, Highland Grow, receives license to sell to other licensed producers from Health Canada
  86. Université de Moncton partners with the Government of Canada, Genome Atlantic, Genome Canada, New Brunswick Innovation Foundation, and Organigram to advance cannabis research and increase productivity
  87. Aurora Cannabis Earnings Kick Off Big Week For Marijuana Stocks After Canada Recreational Legalization
  88. Legalization… What’s Next?  Clear the Smoke at O’Cannabiz Conference and Expo Vancouver
  89. Biome Grow announces supply and production agreement with Province of Newfoundland and Labrador, including distribution and retail services
  90. Trump ousts Jeff Sessions as attorney general
  91. Marijuana Stocks Moved Higher On Election Results
  92. Is the cannabis industry armed against privacy breaches?
  93. Is Emblem Corp (CVE:EMC) A Financially Sound Company?
  94. Midterm elections and marijuana: Part III, recreational use initiatives
  95. Biome Grow’s Announcement in Newfoundland Demonstrates its Large-Scale Commitment to Atlantic Canada
  96. Cannabis Stocks Reversed Some Losses Last Week
  97. O’Cannabiz Vancouver Brings Together Montel Williams, Leading Cannabis Advocates and Innovators
  98. Forget October: Here’s the Right Marijuana Move for Investors Now
  99. Better Marijuana Stock: Canopy Growth vs. Canopy Rivers
  100. Biome Grow (BIO.C) signs huge supply deal with Newfoundland
  101. Aurora Cannabis Receives Lenders’ Consent for Proposed Acquisition of ICC
  102. Spectrum Cannabis welcomes JWC dried cannabis products to its online platform
  103. 3 Marijuana Stocks Taking Advantage of Global CBD Growth
  104. Falling Pot Stocks Hammer Canada’s Struggling Venture Exchange
  105. Cannabis Sector Didn’t Fare So Well Last Week
  106. How Pot Chain MedMen Sounds Like A Typical Retailer With This New Plan
  107. Biome Grow Introduces Ontario-based brand, Great Lakes Cannabis
  108. Kushco Holdings Joins Sustainable Packaging Coalition
  109. Sales of Marijuana in Colorado Continue to Climb
  110. Monday Morning Coming Down
  111. Biome Grow Introduces PEI Brand, Red Sands Craft Cannabis Co.
  112. Mary’s Wellness Pitching CBC Dragon’s Den Tonight
  113. Biome Grow Announces Listing on the Frankfurt Stock Exchange under symbol 60TA
  114. Home-Use THC and CBD Test Kits Now Available in Canada
  115. Looking for Work in Cannabis? Careers Cannabis’ New Platform Launches Today
  116. Canada becomes first industrialised nation to legalise cannabis
  117. Biome Grow is Investing in Atlantic Canadian Cannabis Sector
  118. The Canadian Province With The Most Pot Smokers Was Just Revealed And It’s Not At All Who You Thought It Would Be
  119. The Cannabis Society and Fireside Cannabis presents Canada’s Legalization party.
  120. Cannabis companies ramp up marketing as Health Canada warns them not to advertise pot
  121. CBP Statement on Canada’s Legalization of Marijuana and Crossing the Border
  122. Flower One Commences Trading on the CSE
  123. Canopy Growth Completes First Legal Medical Cannabis Export from Canada to the United States
  124. Aurora Cannabis Announces Application to List on the NYSE
  125. BIOME GROW Begins Trading on CSE Under Symbol (BIO)
  126. Remember When?
  127. NICHE Canada’s Cannabis & Our Community Series Continues in Calgary October 23rd
  128. Biome Grow Closes Fundamental Change Transaction
  129. 10 Of The Richest Cannabis Millionaires — And How They Made Their Money
  130. Cannabis Sector Down After Pepsi’s Statement
  131. Rumors of a Crop Failure at Canopy’s Aldergrove, BC Facility
  132. Dixie Brands, Inc. Going Public, Expanding Operations
  133. As Major Beverage Companies Eye Cannabis Industry, Consumer Trends Expected to Follow Suit
  134. Cannabis company withdraws ‘Chronic by Dre’ trademark it filed without Dr. Dre’s permission
  135. Aphria unveils comprehensive portfolio of adult-use brands
  136. DEA Greenlights Epidiolex. What’s Next for CBD and the Cannabis Industry?
  137. SUPREME CANNABIS SIGNS CANNABIS SUPPLY AGREEMENT WITH TILRAY®
  138. New Ontario Cannabis Regulations Could Be a Breath of Fresh Air
  139. Our first exposure to The Cannabis Society both eye-opening and insightful
  140. Cannabis Sector Stayed in the Green Last Week
  141. Aurora Cannabis releases earnings, confirms U.S. listing plans
  142. Who is Biome Grow and What a Good Business Plan Means to Cannabis Investors
  143. Keep your arms and legs in the car at all times…
  144. Aphria Signs Supply Agreements with all Provinces and Yukon
  145. The Stock That Can’t Stay Out of the News
  146. Tilray Led Cannabis Stocks Higher as Sector Continues to Rally
  147. Tilray Drops Namaste Contract
  148. Coca-Cola and Aurora. Is it the Real Thing?
  149. CEO Hotline – Greg Pantelic, Think AHLOT Corporation
  150. Global Cannabis Partnership Welcomes New Members
  151. iAnthus Capital Holdings, Inc. Announces $30 Million Bought Deal Financing
  152. Organigram signs supply agreement with Newfoundland and Labrador Liquor Corporation
  153. Aphria Announces Director Resignation and Appointment
  154. Emblem launches Atmosphere, Its First Oral Dose-Metered Spray
  155. Organigram invests in Hyasynth Biologicals Inc.
  156. Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
  157. Insights on the Cannabis Industry
  158. Rolling Stone: New Report Predicts CBD Market Will Hit $22 Billion by 2022
  159. NICHE Canada and Aurora Cannabis Launch Guide for Municipal Candidates on Cannabis Legalization and Implementation
  160. Aurora Cannabis-ICC Labs Deal Fuels Marijuana Stock Momentum
  161. EVENT: Cannabis & Our Community – Toronto, Sept 25, 2018
  162. Invictus CEO Update: Building a vertically integrated, horizontally diverse cannabis company
  163. Cannabis Daily and Puffin Style Media Sponsorships
  164. Marijuana Stocks: Short-Seller Citron Research Puts Tilray Stock In Cross Hairs
  165. Demystifying the Science and Economics of Smart Temperature and Humidity Control
  166. Vertical Integration
  167. Take a Deep Dive into Highland Grow’s Antigonish, Nova Scotia Operation
  168. Emerald Health Therapeutics Reports 2nd Quarter 2018 Financial Results and Provides Corporate Update
  169. iAnthus Announces Second Quarter 2018 Financial Results
  170. Starseed Holdings Inc. Launches Saturday, its New Adult-Use Cannabis Brand
  171. Supreme Cannabis Secures Supply Agreements with Nova Scotia and Prince Edward Island
  172. Nova Scotia cannabis distributor hopes local products will be on NSLC shelves by Oct. 17
  173. Cannabis ETF Surges as Alcohol Industry Looks to Marijuana
  174. Aphria selected by the Nova Scotia Liquor Corporation to supply Nova Scotia’s adult-use cannabis market
  175. AB InBev, Pepsi, Coca-Cola All Likely Eyeing Cannabis: Former Alcohol Industry Exec
  176. Biome Grow announces conditional approval for listing on the Canadian Securities Exchange
  177. The Best Under-the-Radar Marijuana Stock I’ve Seen So Far
  178. Biome Grow – Investor Awareness Event
  179. Pot stocks rampage amid expectations of more big deals with traditional companies
  180. Cannabis Daily Launches Cannabis Lifestyle Website
  181. Organigram signs supply agreement with Nova Scotia Liquor Corporation
  182. Cannabis Drinks Expo Announces Canopy Growth Corp. CEO Bruce Linton Will Headline Event
  183. Aurora Cannabis Obtains Health Canada Approval for Softgel Capsule Production: Launches CanniMed Capsules 3:3
  184. The MJBizCon Int’l Conference Brought American Canna-Business to Toronto
  185. Aphria Signs Agreement with OCS
  186. The OCS Announces its Suppliers
  187. Emerald Health Therapeutics Announces Appointment of Pure Sunfarms President and CEO
  188. Weed’s Big Day
  189. The Green Organic Dutchman Signs Agreement to Acquire Leading European CBD Company HemPoland
  190. Let's Face It: Marijuana Stocks Won't Live Up to the Hype
  191. Aurora Cannabis and MedReleaf Confirm Supply Agreements with Ontario Cannabis Stores
  192. Organigram becomes an official cannabis supplier to the Province of Ontario, Canada’s largest adult recreational market
  193. Canopy Growth secures over 100 product listings in Ontario
  194. The Google of Cannabis? Hmm…
  195. Dry Counties
  196. TGOD Reports $8.5M Loss for Quarter ended June 30, 2018
  197. Kush Bottles Launches Their Canadian Division
  198. Cannabis company Canopy Growth’s stock soars 30% as Corona brewer increases stake
  199. Aurora Cannabis and McGill University Partner in International Research Project
  200. Constellation Brands makes additional $4 billion investment in cannabis company Canopy Growth
  201. Are Cannabis Investors Forgetting the Lessons of the Dot Com Era? First-to-Market May Not Win.
  202. THC BioMed Develops Cannabis Beverage
  203. What’s the Analyst Consensus on Aphria?
  204. Canopy Growth Completes Canopy Health Innovations Acquisition
  205. Has Canadian Marijuana Officially Bypassed Mainstream and Gone Corporate?
  206. How Trump’s trade battles are affecting the marijuana industry
  207. Aphria Records Higher Annual Sales and Higher Quarterly Loss Due to Pending Canadian Legalization
  208. 48North Invites Women To Speak-Up About Their Cannabis Use
  209. ABcann to Acquire Leading B.C. Producer Canna Farms
  210. Ontario said to announce big change in plans for marijuana retailing under Doug Ford
  211. The Greenfield 4:20 Fire and its Implications
  212. Aurora Cannabis and MedReleaf Close the World’s Largest Cannabis Industry Transaction
  213. CEO Hotline: Khurram Malik, Interim CEO, Biome Grow
  214. Marijuana operator Acreage Holdings announces landmark $119 million funding
  215. Cannabis Sector Continued to Slide Last Week
  216. Aphria provides update on investments
  217. Aurora, MedReleaf shareholders clear path toward Canada’s largest cannabis deal
  218. Step into the first virtual reality cannabis dispensary
  219. One Stop Shops? Not with the Kids. NSLC Shows Their Store.
  220. Khiron Appoints Former Mexican President Vicente Fox to Board of Directors
  221. Selling Cannabis in Jamaica – Wait…What?
  222. Aurora Cannabis Selects Shopify to Power Global ECommerce Platform
  223. British Columbia’s Liquor Board Announces the Province’s 31 Bud Suppliers
  224. Kush Bottles Reports Third Fiscal Quarter 2018 Results, Name Change and Restructuring
  225. Canopy Growth Moves to Acquire Hiku Brands Company
  226. Biome Grow Announces Appointment of Steven Poirier to its Board of Directors
  227. Alberta Announces the ‘Lucky 13’
  228. Canada to legalise smoking pot: Can these stocks smoke the ASX?
  229. Legal Marijuana Is Coming to Canada. Investors Catch the Buzz.
  230. Analyst Recommendations for Two Leading Cannabis Stocks
  231. Cannabis Promotion in Canada? See Tobacco. Tobacco Promotion in Canada? See Kryptonite.
  232. CEO of the Green Organic Dutchmen Resigns, New CEO and CFO Appointed
  233. 3 Best Marijuana Stocks of 2018 So Far — Are They Buys Now?
  234. CEO Hotline: The Cannabis Executive Search Agency
  235. Canadian Company Makes Historic Investment in Jamaican Medical Cannabis Research
  236. Orca Touchscreen Technologies Shareholders Approve Amalgamation with Biome Grow
  237. Why Canopy Growth Corp’s Shares Plunged 12% Today
  238. TGOD Holdings Accelerates European Expansion with Denmark Joint Venture
  239. Cann Group secures Australia’s largest medicinal cannabis operation
  240. Top Four Developments We’re Watching in Cannabis Sector: Part 2
  241. Aurora Cannabis signs loan deal for up to $250 million with Bank of Montreal
  242. Cannabis Drinks Gaining Visibility
  243. B.C. Announces Central Cannabis Warehouse and Online Platform
  244. Six Key Differentiation Points for the Cannabis Market in Canada
  245. Canada Legalizes Recreational Marijuana: What’s Next for Pot Stocks?
  246. Cultivator Catalyst Corp to go public with tech firm Orca
  247. Move Over Tech: Marijuana Stocks Are the New Star
  248. The Post-Prohibition Era in Canada Begins
  249. Canadian Senate Approves Bill C-45
  250. High Times refreshes IPO plans as cannabis companies build buzz on Wall Street
  251. Weed VR – Future Tech Today
  252. 48North Launches Scholarship Program for Entrepreneurial Women in Cannabis
  253. CannTrust strives to be a leader in the cannabis industry with a 450,000 square foot facility in Niagara, ON.
  254. Biome Grow announces agreement to acquire Weed Virtual Retail
  255. Here’s how Canada compares with the rest of the world when it comes to cannabis legalization
  256. CannabisMD and CBD’s Medicinal Application
  257. Khiron Life Sciences First To Enter 5-Million Strong Colombia Medical Cannabis Market
  258. House of Commons to Reinstate Rights of Canadians to Grow Cannabis
  259. Welcome to Cannada -Part 3. The New Cannabis Economy
  260. Cannabis Delivery Services: Curation and Connection
  261. Avoid These Obvious Mistakes When Investing In Cannabis Stocks
  262. 5 Must-See Quotes From Aurora Cannabis on Worldwide Weed Opportunities
  263. Trump Signals Support for Legislation Easing US Ban on Pot
  264. Large Indoor Hydroponic Facility – New On the CSE
  265. A Hitchhiker’s Guide to Recreational Cannabis
  266. CEO of Lift & Co’s Consumer-Centric Vision
  267. On the Morning of Canadian Senate Vote, Weed Stocks Down
  268. 2nd Annual O’Cannabiz Conference Toronto
  269. Now Growing More Than Tomatoes & Cucumbers
  270. Welcome to Cannada -Part 2. The Cannabis Stock Exchange
  271. Newfoundland and Labrador’s Back Home Medical Cannabis Corp. becoming a reality thanks to investment from Biome Grow
  272. Welcome to Cannada. Part I – The Canadian Cannabis Future
  273. Deloitte Reports that Canadians Will Spend $7.2B Next Year on Cannabis
  274. As C-45 Passage Approaches, Greg Engel, CEO of OrganiGram, Shares His Thoughts
  275. Organigram Enters into Non-Binding Term Sheet for 26% Equity Interest in Eviana Health Corporation
  276. On the Verge of Becoming Canada’s Largest Cannabis Producer
  277. Khiron Life Sciences Corp. New on the TSX – Medical Cannabis for Latin America
  278. C-45 Progresses in the Canadian Senate as the Industry Ramps Up
  279. 8 Canadian Marijuana Growers Expected to Top 100,000 Kilograms of Annual Production
  280. Canopy Growth Announces Five Retail Locations in Saskatchewan
  281. MedMen CEO Sees Untapped Potential in Marijuana Market
  282. Canopy Growth Corporation announces entry into the African market with acquisition of Daddy Cann Lesotho
  283. Meet Nova Scotia’s 3 legal cannabis growers
  284. JMCC Aims to Supply Canadian LPs with Jamaican Premium Cannabis
  285. MedMen Begins Trading Under Ticker Symbol “MMEN” on the Canadian Securities Exchange
  286. MedReleaf and BioPharma Services Inc. Announce Strategic Alliance
  287. Cannabis Sector Back in the Red for Week Ended May 25
  288. What Investors Are Paying for Cannabis Sector’s Forward Sales
  289. As Ontario Votes, We Ask the Candidates Where They Stand on Cannabis.
  290. Biome announces acquisition of land in Nova Scotia to dramatically increase the production footprint of its ACMPR Licensed Producer
  291. With Legalization Colorado Invited Growers into the State. Here’s What Happened
  292. Looking for Work Women? Perhaps the Grass is Greener in the Cannabis Industry
  293. Organigram Announces Letter of Intent for Strategic Investment in Hyasynth Biologicals Inc.
  294. Highland Grow Inc. Boosts its Quality Assurance and Regulatory Compliance Ranks
  295. Lift & Co. Cannabis Expo Illustrates the Changing Nature of the Business
  296. Diagnostics, Testing and Support – The Coming Wave
  297. From the Big Smoke to the Big Board
  298. Biome Grow expects completion of first province-based cannabis production facility this year
  299. Oils – Are They Secret Sauce to Profitability?
  300. Organigram Receives Permit to Export Medical Cannabis to Australia
  301. Morning Briefing -Top 9 Stocks To Follow
  302. Biome Grow Expects to Complete First Newfoundland and Labrador-based Cannabis Production Facility in 2018
  303. Biome Grow Announces Name Change of its Nova Scotia-Based ACMPR Licensed Producer to Highland Grow Inc.
  304. Organigram Unveils Comprehensive Suite of Adult Recreational Cannabis Brands
  305. Organigram Announces Receipt of License for Controlled Drugs and Substances from Health Canada
  306. Cannabis Stocks Heat Up on News of $3.2 Billion Aurora & MedReleaf Deal
  307. Aurora Cannabis to Acquire MedReleaf
  308. Opportunity Watchlist: Orca Touchscreen & Cultivator Catalyst Corp. Amalgamation to ‘Biome Grow Inc.’
  309. New on the TSX: InMed Pharmaceuticals
  310. Canadian Cannabis Stocks Continue to Dominate the Market
  311. Organigram Announces First International Expansion Investment
  312. Moody’s Expects Marijuana to See Limited Revenue
  313. Tweed Announces Location of Newfoundland Production Site and First Retail Locations
  314. How to Invest in Cannabis – In Its Many Forms
  315. Should You Invest In Cannabis Stocks?
  316. Top 4 Marijuana Stocks to Watch
  317. CEO Hotline Puts You In The Know
  318. 10 Canadian Marijuana Stocks for Your Portfolio
  319. Pot Stocks To Buy Now
  320. High Hampton Holdings Offers Investors Smart, Diversified Exposure to North America’s Fastest-Growing Marijuana Market
  321. MedMen in Binding ‘Letter of Intent’ To Merge Into Public Company in Canada
  322. American Cannabis Stocks
  323. Orca Touchscreen Enters Into Letter of Intent With Cultivator Catalyst Corp.
  324. Saw that it was covered
  325. Chooses to enjoy a pleasure
  326. These matters to this principle
  327. Heaven and earth seem
  328. Had grass morning
  329. Where they abused her
  330. Replenish itself
  331. I neglect my talents
  332. Grammar resulting language
  333. Where it came from it
Banner Top
  1. Canopy Growth Corporation Reports Third Quarter Fiscal 2019 Financial Results:
  2. Treating Yourself Relaunches Medical Cannabis Website
  3. Sunniva Announces Completion of $15 Million Convertible Debenture Financing
  4. Supreme Cannabis Announces Q2 2019 Financial Results
  5. ‘This is the new Vitamin C’: Biome Grow to sign major CBD source deal
  6. Could Cannabis Cosmeceuticals be the Next Billion Dollar Idea?
  7. Biome Grow announces Memorandum of Understanding to purchase up to 20,000 kg per year of hemp-grown CBD extract from industrial hemp grower CBD Acres
  8. Aurora Releases Q2 Financial Results
  9. O’Cannabiz Toronto Expo, Conference & Industry Awards April 25-27 2019
  10. Biome Grow announces first shipment of finished product to Newfoundland and Labrador
  11. Supreme Cannabis Expands Domestic Distribution to Eight Provinces
  12. 48North Closes its $10 million Private Placement
  13. Aphria’s Board of Directors Rejects Green Growth Brand’s Hostile Takeover Bid
  14. Planet 13 Announces Customer Traffic for January 2019
  15. iAnthus and MPX Bioceutical Announce Closing of $1.6 Billion Business Combination
  16. Namaste Board Launches Strategic Review Process; Announces Termination of CEO Sean Dollinger and Commences Legal Action
  17. World Health Organization Recommends Rescheduling Marijuana Under International Treaties
  18. What Drove Altria’s Revenue in the Fourth Quarter?
  19. Surprise! Tilray’s CEO Just Dumped $11 Million in Stock
  20. Origin House Signs Exclusive Distribution Agreement and Provides Strategic Financing to Utopia Cannabis
  21. Slang, a Canopy Growth-backed Cannabis Company on CSE, off to Half-Billion Dollar Valuation
  22. PharmaCielo Establishes Joint Venture with Mino Labs to Bring Medicinal Cannabis Oil to Mexico
  23. Origin House Signs Exclusive Agreement with Viola Brands for California
  24. TGOD Completes Knud Jepsen Agreement
  25. Green Growth Brands Files Offer to Purchase and Circular for Aphria Inc.; Aphria Urges Shareholders to “Take No Action”
  26. MPX Receives Final Court Approval for Arrangement with iAnthus
  27. Invictus MD Announces Submission Of Its Application To List On NASDAQ And Share Consolidation
  28. HEXO to Begin Trading on the NYSE American, Announces Results of AGM
  29. Nova Scotia’s Highland Grow Secures Second Purchase Order with the NSLC
  30. MPX Securityholders Approve Business Combination with iAnthus
  31. Invictus and GTEC Holdings Announce Formal Termination Of Merger Plans
  32. Biome Opens the Door to U.S. Investors
  33. Aleafia Fulfills First Transaction Under Cannabis Supply Agreement with CannTrust
  34. Aurora to Acquire Whistler
  35. Aphria Releases Q2 Results as Founders Step Down
  36. Curaleaf Set To Expand Operations In Maryland With New Financing And Purchase Option Agreements
  37. PharmaCielo Announces TSX Venture Listing and Provides Corporate Update
  38. Emerald Health Closes Emerald Health Naturals Joint Venture
  39. Biome Grow subsidiary, Highland Grow secures purchase order with NSLC and sends first shipment of finished product
  40. SUPREME CANNABIS RECEIVES CONDITIONAL APPROVAL TO LIST ON THE TORONTO STOCK EXCHANGE
  41. KUSHCO HOLDINGS REPORTS FIRST FISCAL QUARTER 2019 RESULTS
  42. Aurora Cannabis Provides Guidance for the Second Quarter of Fiscal 2019, Anticipating Net Revenues of $50M to $55M
  43. Curaleaf Launches Its 20th Medical Marijuana Dispensary in Florida
  44. iAnthus Opens Flagship Citiva Dispensary in Brooklyn
  45. TGOD Signs a Commercial Sublicense with EnWave and Tilray to Dry Cannabis in Canada
  46. The Fastest-Growing Marijuana Stocks in 2019
  47. Biome Announces OTCQB Listing
  48. Green Growth Brands Launches Hostile Takeover Bid for Aphria Inc.
  49. Cannabis Stocks Mixed on Monday
  50. Health Canada Announces Proposed Regulations for Cannabis Edibles, Extracts, and Topicals
  51. Northland Capital Initiates Coverage on Planet 13 Holdings
  52. Details on Ontario’s New Private Cannabis Retail Lottery
  53. GrowHealthy Opens First Flagship Dispensary in Florida, With Plans for Two More by End of 2018
  54. Biome Grow Receives Amended Health Canada Sales License for its Nova Scotia-based Highland Grow.
  55. Canada’s Largest Province To Approve Only 25 Store Licences Due to Supply Shortage
  56. The Next Cannabis Wave? A $3.7 Trillion Wellness Market
  57. Canopy Growth announces multi-year extraction agreement with Valens GroWorks
  58. Here’s Why Marijuana Stocks Deserve Coal in Their Stockings This Year
  59. Biome Receives DTC Eligibility in United States, OTC symbol “ORTFF”
  60. U.S. House of Representatives Passes the Farm Bill
  61. Mississauga and Markham Opt-Out of Cannabis Retail Stores
  62. Interview with Diane Scott, Chairman and Chief Executive Officer, Jamaican Medical Cannabis Corporation (JMCC)
  63. Canada’s Aurora Cannabis buys Mexico’s Farmacias Magistrales
  64. Altria Moves into the Herd
  65. Cronos group inc. Announces c$2.4 billion strategic investment from altria group, inc
  66. Canopy Acquires Storz & Bickel
  67. CANNABIS MEETS HEALTHCARE
  68. Aphria Shares Down this Morning
  69. 48North Has Two Major Announcements
  70. Cannabis stock report: Congress agrees on new farm bill legislation, CBD industry readies to explode
  71. Cannabis Daily’s Top 35 Stocks Now Updated
  72. iAnthus Announces Third Quarter 2018 Financial Results
  73. Green Thumb Industries (GTI) Announces Year-over-Year Revenue Growth of 344% and Sequential Revenue Growth of 26% for Third Quarter 2018
  74. 48North Cannabis Corp. Announces Revenue Growth for Fiscal Q1 2019
  75. KUSHCO HOLDINGS REPORTS FISCAL YEAR 2018 RESULTS
  76. Canada’s Grand Cannabis Experiment Has Set Scientists Free
  77. What Did Canadian Cannabis Legalization Do to the Stock Markets?
  78. Cannabis 3.0?
  79. Cannabis firms spent millions marketing their pot last quarter – did it work?
  80. Biome Grow, Now Publicly Traded but Falling Under the Radar
  81. John Boehner-Backed Pot Firm Sees This Boosting U.S. Weed Listings
  82. MJBizCon Las Vegas Redefines Scale in Cannabis Trade Shows
  83. Ontario Establishes Strict Regulations for the Licensing and Operation of Private Cannabis Stores
  84. Canopy Growth Losses Widen Sharply, But Cannabis Sales Prices Spike
  85. Biome Grow subsidiary, Highland Grow, receives license to sell to other licensed producers from Health Canada
  86. Université de Moncton partners with the Government of Canada, Genome Atlantic, Genome Canada, New Brunswick Innovation Foundation, and Organigram to advance cannabis research and increase productivity
  87. Aurora Cannabis Earnings Kick Off Big Week For Marijuana Stocks After Canada Recreational Legalization
  88. Legalization… What’s Next?  Clear the Smoke at O’Cannabiz Conference and Expo Vancouver
  89. Biome Grow announces supply and production agreement with Province of Newfoundland and Labrador, including distribution and retail services
  90. Trump ousts Jeff Sessions as attorney general
  91. Marijuana Stocks Moved Higher On Election Results
  92. Is the cannabis industry armed against privacy breaches?
  93. Is Emblem Corp (CVE:EMC) A Financially Sound Company?
  94. Midterm elections and marijuana: Part III, recreational use initiatives
  95. Biome Grow’s Announcement in Newfoundland Demonstrates its Large-Scale Commitment to Atlantic Canada
  96. Cannabis Stocks Reversed Some Losses Last Week
  97. O’Cannabiz Vancouver Brings Together Montel Williams, Leading Cannabis Advocates and Innovators
  98. Forget October: Here’s the Right Marijuana Move for Investors Now
  99. Better Marijuana Stock: Canopy Growth vs. Canopy Rivers
  100. Biome Grow (BIO.C) signs huge supply deal with Newfoundland
  101. Aurora Cannabis Receives Lenders’ Consent for Proposed Acquisition of ICC
  102. Spectrum Cannabis welcomes JWC dried cannabis products to its online platform
  103. 3 Marijuana Stocks Taking Advantage of Global CBD Growth
  104. Falling Pot Stocks Hammer Canada’s Struggling Venture Exchange
  105. Cannabis Sector Didn’t Fare So Well Last Week
  106. How Pot Chain MedMen Sounds Like A Typical Retailer With This New Plan
  107. Biome Grow Introduces Ontario-based brand, Great Lakes Cannabis
  108. Kushco Holdings Joins Sustainable Packaging Coalition
  109. Sales of Marijuana in Colorado Continue to Climb
  110. Monday Morning Coming Down
  111. Biome Grow Introduces PEI Brand, Red Sands Craft Cannabis Co.
  112. Mary’s Wellness Pitching CBC Dragon’s Den Tonight
  113. Biome Grow Announces Listing on the Frankfurt Stock Exchange under symbol 60TA
  114. Home-Use THC and CBD Test Kits Now Available in Canada
  115. Looking for Work in Cannabis? Careers Cannabis’ New Platform Launches Today
  116. Canada becomes first industrialised nation to legalise cannabis
  117. Biome Grow is Investing in Atlantic Canadian Cannabis Sector
  118. The Canadian Province With The Most Pot Smokers Was Just Revealed And It’s Not At All Who You Thought It Would Be
  119. The Cannabis Society and Fireside Cannabis presents Canada’s Legalization party.
  120. Cannabis companies ramp up marketing as Health Canada warns them not to advertise pot
  121. CBP Statement on Canada’s Legalization of Marijuana and Crossing the Border
  122. Flower One Commences Trading on the CSE
  123. Canopy Growth Completes First Legal Medical Cannabis Export from Canada to the United States
  124. Aurora Cannabis Announces Application to List on the NYSE
  125. BIOME GROW Begins Trading on CSE Under Symbol (BIO)
  126. Remember When?
  127. NICHE Canada’s Cannabis & Our Community Series Continues in Calgary October 23rd
  128. Biome Grow Closes Fundamental Change Transaction
  129. 10 Of The Richest Cannabis Millionaires — And How They Made Their Money
  130. Cannabis Sector Down After Pepsi’s Statement
  131. Rumors of a Crop Failure at Canopy’s Aldergrove, BC Facility
  132. Dixie Brands, Inc. Going Public, Expanding Operations
  133. As Major Beverage Companies Eye Cannabis Industry, Consumer Trends Expected to Follow Suit
  134. Cannabis company withdraws ‘Chronic by Dre’ trademark it filed without Dr. Dre’s permission
  135. Aphria unveils comprehensive portfolio of adult-use brands
  136. DEA Greenlights Epidiolex. What’s Next for CBD and the Cannabis Industry?
  137. SUPREME CANNABIS SIGNS CANNABIS SUPPLY AGREEMENT WITH TILRAY®
  138. New Ontario Cannabis Regulations Could Be a Breath of Fresh Air
  139. Our first exposure to The Cannabis Society both eye-opening and insightful
  140. Cannabis Sector Stayed in the Green Last Week
  141. Aurora Cannabis releases earnings, confirms U.S. listing plans
  142. Who is Biome Grow and What a Good Business Plan Means to Cannabis Investors
  143. Keep your arms and legs in the car at all times…
  144. Aphria Signs Supply Agreements with all Provinces and Yukon
  145. The Stock That Can’t Stay Out of the News
  146. Tilray Led Cannabis Stocks Higher as Sector Continues to Rally
  147. Tilray Drops Namaste Contract
  148. Coca-Cola and Aurora. Is it the Real Thing?
  149. CEO Hotline – Greg Pantelic, Think AHLOT Corporation
  150. Global Cannabis Partnership Welcomes New Members
  151. iAnthus Capital Holdings, Inc. Announces $30 Million Bought Deal Financing
  152. Organigram signs supply agreement with Newfoundland and Labrador Liquor Corporation
  153. Aphria Announces Director Resignation and Appointment
  154. Emblem launches Atmosphere, Its First Oral Dose-Metered Spray
  155. Organigram invests in Hyasynth Biologicals Inc.
  156. Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
  157. Insights on the Cannabis Industry
  158. Rolling Stone: New Report Predicts CBD Market Will Hit $22 Billion by 2022
  159. NICHE Canada and Aurora Cannabis Launch Guide for Municipal Candidates on Cannabis Legalization and Implementation
  160. Aurora Cannabis-ICC Labs Deal Fuels Marijuana Stock Momentum
  161. EVENT: Cannabis & Our Community – Toronto, Sept 25, 2018
  162. Invictus CEO Update: Building a vertically integrated, horizontally diverse cannabis company
  163. Cannabis Daily and Puffin Style Media Sponsorships
  164. Marijuana Stocks: Short-Seller Citron Research Puts Tilray Stock In Cross Hairs
  165. Demystifying the Science and Economics of Smart Temperature and Humidity Control
  166. Vertical Integration
  167. Take a Deep Dive into Highland Grow’s Antigonish, Nova Scotia Operation
  168. Emerald Health Therapeutics Reports 2nd Quarter 2018 Financial Results and Provides Corporate Update
  169. iAnthus Announces Second Quarter 2018 Financial Results
  170. Starseed Holdings Inc. Launches Saturday, its New Adult-Use Cannabis Brand
  171. Supreme Cannabis Secures Supply Agreements with Nova Scotia and Prince Edward Island
  172. Nova Scotia cannabis distributor hopes local products will be on NSLC shelves by Oct. 17
  173. Cannabis ETF Surges as Alcohol Industry Looks to Marijuana
  174. Aphria selected by the Nova Scotia Liquor Corporation to supply Nova Scotia’s adult-use cannabis market
  175. AB InBev, Pepsi, Coca-Cola All Likely Eyeing Cannabis: Former Alcohol Industry Exec
  176. Biome Grow announces conditional approval for listing on the Canadian Securities Exchange
  177. The Best Under-the-Radar Marijuana Stock I’ve Seen So Far
  178. Biome Grow – Investor Awareness Event
  179. Pot stocks rampage amid expectations of more big deals with traditional companies
  180. Cannabis Daily Launches Cannabis Lifestyle Website
  181. Organigram signs supply agreement with Nova Scotia Liquor Corporation
  182. Cannabis Drinks Expo Announces Canopy Growth Corp. CEO Bruce Linton Will Headline Event
  183. Aurora Cannabis Obtains Health Canada Approval for Softgel Capsule Production: Launches CanniMed Capsules 3:3
  184. The MJBizCon Int’l Conference Brought American Canna-Business to Toronto
  185. Aphria Signs Agreement with OCS
  186. The OCS Announces its Suppliers
  187. Emerald Health Therapeutics Announces Appointment of Pure Sunfarms President and CEO
  188. Weed’s Big Day
  189. The Green Organic Dutchman Signs Agreement to Acquire Leading European CBD Company HemPoland
  190. Let's Face It: Marijuana Stocks Won't Live Up to the Hype
  191. Aurora Cannabis and MedReleaf Confirm Supply Agreements with Ontario Cannabis Stores
  192. Organigram becomes an official cannabis supplier to the Province of Ontario, Canada’s largest adult recreational market
  193. Canopy Growth secures over 100 product listings in Ontario
  194. The Google of Cannabis? Hmm…
  195. Dry Counties
  196. TGOD Reports $8.5M Loss for Quarter ended June 30, 2018
  197. Kush Bottles Launches Their Canadian Division
  198. Cannabis company Canopy Growth’s stock soars 30% as Corona brewer increases stake
  199. Aurora Cannabis and McGill University Partner in International Research Project
  200. Constellation Brands makes additional $4 billion investment in cannabis company Canopy Growth
  201. Are Cannabis Investors Forgetting the Lessons of the Dot Com Era? First-to-Market May Not Win.
  202. THC BioMed Develops Cannabis Beverage
  203. What’s the Analyst Consensus on Aphria?
  204. Canopy Growth Completes Canopy Health Innovations Acquisition
  205. Has Canadian Marijuana Officially Bypassed Mainstream and Gone Corporate?
  206. How Trump’s trade battles are affecting the marijuana industry
  207. Aphria Records Higher Annual Sales and Higher Quarterly Loss Due to Pending Canadian Legalization
  208. 48North Invites Women To Speak-Up About Their Cannabis Use
  209. ABcann to Acquire Leading B.C. Producer Canna Farms
  210. Ontario said to announce big change in plans for marijuana retailing under Doug Ford
  211. The Greenfield 4:20 Fire and its Implications
  212. Aurora Cannabis and MedReleaf Close the World’s Largest Cannabis Industry Transaction
  213. CEO Hotline: Khurram Malik, Interim CEO, Biome Grow
  214. Marijuana operator Acreage Holdings announces landmark $119 million funding
  215. Cannabis Sector Continued to Slide Last Week
  216. Aphria provides update on investments
  217. Aurora, MedReleaf shareholders clear path toward Canada’s largest cannabis deal
  218. Step into the first virtual reality cannabis dispensary
  219. One Stop Shops? Not with the Kids. NSLC Shows Their Store.
  220. Khiron Appoints Former Mexican President Vicente Fox to Board of Directors
  221. Selling Cannabis in Jamaica – Wait…What?
  222. Aurora Cannabis Selects Shopify to Power Global ECommerce Platform
  223. British Columbia’s Liquor Board Announces the Province’s 31 Bud Suppliers
  224. Kush Bottles Reports Third Fiscal Quarter 2018 Results, Name Change and Restructuring
  225. Canopy Growth Moves to Acquire Hiku Brands Company
  226. Biome Grow Announces Appointment of Steven Poirier to its Board of Directors
  227. Alberta Announces the ‘Lucky 13’
  228. Canada to legalise smoking pot: Can these stocks smoke the ASX?
  229. Legal Marijuana Is Coming to Canada. Investors Catch the Buzz.
  230. Analyst Recommendations for Two Leading Cannabis Stocks
  231. Cannabis Promotion in Canada? See Tobacco. Tobacco Promotion in Canada? See Kryptonite.
  232. CEO of the Green Organic Dutchmen Resigns, New CEO and CFO Appointed
  233. 3 Best Marijuana Stocks of 2018 So Far — Are They Buys Now?
  234. CEO Hotline: The Cannabis Executive Search Agency
  235. Canadian Company Makes Historic Investment in Jamaican Medical Cannabis Research
  236. Orca Touchscreen Technologies Shareholders Approve Amalgamation with Biome Grow
  237. Why Canopy Growth Corp’s Shares Plunged 12% Today
  238. TGOD Holdings Accelerates European Expansion with Denmark Joint Venture
  239. Cann Group secures Australia’s largest medicinal cannabis operation
  240. Top Four Developments We’re Watching in Cannabis Sector: Part 2
  241. Aurora Cannabis signs loan deal for up to $250 million with Bank of Montreal
  242. Cannabis Drinks Gaining Visibility
  243. B.C. Announces Central Cannabis Warehouse and Online Platform
  244. Six Key Differentiation Points for the Cannabis Market in Canada
  245. Canada Legalizes Recreational Marijuana: What’s Next for Pot Stocks?
  246. Cultivator Catalyst Corp to go public with tech firm Orca
  247. Move Over Tech: Marijuana Stocks Are the New Star
  248. The Post-Prohibition Era in Canada Begins
  249. Canadian Senate Approves Bill C-45
  250. High Times refreshes IPO plans as cannabis companies build buzz on Wall Street
  251. Weed VR – Future Tech Today
  252. 48North Launches Scholarship Program for Entrepreneurial Women in Cannabis
  253. CannTrust strives to be a leader in the cannabis industry with a 450,000 square foot facility in Niagara, ON.
  254. Biome Grow announces agreement to acquire Weed Virtual Retail
  255. Here’s how Canada compares with the rest of the world when it comes to cannabis legalization
  256. CannabisMD and CBD’s Medicinal Application
  257. Khiron Life Sciences First To Enter 5-Million Strong Colombia Medical Cannabis Market
  258. House of Commons to Reinstate Rights of Canadians to Grow Cannabis
  259. Welcome to Cannada -Part 3. The New Cannabis Economy
  260. Cannabis Delivery Services: Curation and Connection
  261. Avoid These Obvious Mistakes When Investing In Cannabis Stocks
  262. 5 Must-See Quotes From Aurora Cannabis on Worldwide Weed Opportunities
  263. Trump Signals Support for Legislation Easing US Ban on Pot
  264. Large Indoor Hydroponic Facility – New On the CSE
  265. A Hitchhiker’s Guide to Recreational Cannabis
  266. CEO of Lift & Co’s Consumer-Centric Vision
  267. On the Morning of Canadian Senate Vote, Weed Stocks Down
  268. 2nd Annual O’Cannabiz Conference Toronto
  269. Now Growing More Than Tomatoes & Cucumbers
  270. Welcome to Cannada -Part 2. The Cannabis Stock Exchange
  271. Newfoundland and Labrador’s Back Home Medical Cannabis Corp. becoming a reality thanks to investment from Biome Grow
  272. Welcome to Cannada. Part I – The Canadian Cannabis Future
  273. Deloitte Reports that Canadians Will Spend $7.2B Next Year on Cannabis
  274. As C-45 Passage Approaches, Greg Engel, CEO of OrganiGram, Shares His Thoughts
  275. Organigram Enters into Non-Binding Term Sheet for 26% Equity Interest in Eviana Health Corporation
  276. On the Verge of Becoming Canada’s Largest Cannabis Producer
  277. Khiron Life Sciences Corp. New on the TSX – Medical Cannabis for Latin America
  278. C-45 Progresses in the Canadian Senate as the Industry Ramps Up
  279. 8 Canadian Marijuana Growers Expected to Top 100,000 Kilograms of Annual Production
  280. Canopy Growth Announces Five Retail Locations in Saskatchewan
  281. MedMen CEO Sees Untapped Potential in Marijuana Market
  282. Canopy Growth Corporation announces entry into the African market with acquisition of Daddy Cann Lesotho
  283. Meet Nova Scotia’s 3 legal cannabis growers
  284. JMCC Aims to Supply Canadian LPs with Jamaican Premium Cannabis
  285. MedMen Begins Trading Under Ticker Symbol “MMEN” on the Canadian Securities Exchange
  286. MedReleaf and BioPharma Services Inc. Announce Strategic Alliance
  287. Cannabis Sector Back in the Red for Week Ended May 25
  288. What Investors Are Paying for Cannabis Sector’s Forward Sales
  289. As Ontario Votes, We Ask the Candidates Where They Stand on Cannabis.
  290. Biome announces acquisition of land in Nova Scotia to dramatically increase the production footprint of its ACMPR Licensed Producer
  291. With Legalization Colorado Invited Growers into the State. Here’s What Happened
  292. Looking for Work Women? Perhaps the Grass is Greener in the Cannabis Industry
  293. Organigram Announces Letter of Intent for Strategic Investment in Hyasynth Biologicals Inc.
  294. Highland Grow Inc. Boosts its Quality Assurance and Regulatory Compliance Ranks
  295. Lift & Co. Cannabis Expo Illustrates the Changing Nature of the Business
  296. Diagnostics, Testing and Support – The Coming Wave
  297. From the Big Smoke to the Big Board
  298. Biome Grow expects completion of first province-based cannabis production facility this year
  299. Oils – Are They Secret Sauce to Profitability?
  300. Organigram Receives Permit to Export Medical Cannabis to Australia
  301. Morning Briefing -Top 9 Stocks To Follow
  302. Biome Grow Expects to Complete First Newfoundland and Labrador-based Cannabis Production Facility in 2018
  303. Biome Grow Announces Name Change of its Nova Scotia-Based ACMPR Licensed Producer to Highland Grow Inc.
  304. Organigram Unveils Comprehensive Suite of Adult Recreational Cannabis Brands
  305. Organigram Announces Receipt of License for Controlled Drugs and Substances from Health Canada
  306. Cannabis Stocks Heat Up on News of $3.2 Billion Aurora & MedReleaf Deal
  307. Aurora Cannabis to Acquire MedReleaf
  308. Opportunity Watchlist: Orca Touchscreen & Cultivator Catalyst Corp. Amalgamation to ‘Biome Grow Inc.’
  309. New on the TSX: InMed Pharmaceuticals
  310. Canadian Cannabis Stocks Continue to Dominate the Market
  311. Organigram Announces First International Expansion Investment
  312. Moody’s Expects Marijuana to See Limited Revenue
  313. Tweed Announces Location of Newfoundland Production Site and First Retail Locations
  314. How to Invest in Cannabis – In Its Many Forms
  315. Should You Invest In Cannabis Stocks?
  316. Top 4 Marijuana Stocks to Watch
  317. CEO Hotline Puts You In The Know
  318. 10 Canadian Marijuana Stocks for Your Portfolio
  319. Pot Stocks To Buy Now
  320. High Hampton Holdings Offers Investors Smart, Diversified Exposure to North America’s Fastest-Growing Marijuana Market
  321. MedMen in Binding ‘Letter of Intent’ To Merge Into Public Company in Canada
  322. American Cannabis Stocks
  323. Orca Touchscreen Enters Into Letter of Intent With Cultivator Catalyst Corp.
  324. Saw that it was covered
  325. Chooses to enjoy a pleasure
  326. These matters to this principle
  327. Heaven and earth seem
  328. Had grass morning
  329. Where they abused her
  330. Replenish itself
  331. I neglect my talents
  332. Grammar resulting language
  333. Where it came from it

By  – InvestingNews.com March 26th, 2018

Agritek Holdings (OTCMKTS:AGTK)

Agritek is a real estate investor dedicated to the cannabis sector, they also act as consultants for a variety of cannabis brands like California Premiums, Hemp Pops and MicroDose Strips, all offering different types of products.

As part of a letter to shareholders, CEO Michael Friedman said this year the company plans to keep up their momentum from their most recent acquisitions. Moving forward the company is working on the expansion of their developing facilities. “The current year is expected to be a busy year of development and expansion of our multi-pronged real estate and branding company catering to the marijuana industry,” Friedman wrote in his letter.

ABcann Global (OTC:ABCCF)

ABcann is a production company with a licensed facility in Ontario. In January the company completed a $70 million financing deal with Canaccord Genuity and Eight Capital. ABcann also received an import license from the Federal Office of Drug Control in Australia, allowing the company to supply medicinal cannabis to the Australian market.

“This import license is a key milestone towards generating revenue through ABcann’s network of physicians, pharmacists and patients, and advancing the use of medical cannabis,” Barry Fishman, CEO of ABcann said in a statement.

American Cannabis Company (OTC:AMMJ)

This company brings their expertise to other players in the cannabis space offering business planning and market assessment services. The company also sells ancillary products focused on this specific market. So far this year, the company has signed two new contracts with cannabis clients focused on the state of California.

AmeriCann (OTCQX:ACAN)

AmeriCann is an agricultural technology company working on the consultation, design, construction, and financing of facilities for approved and licensed marijuana operators throughout the United States. The company is currently engaged in three facility projects, in three separate states, Denver, Massachusetts, and Illinois. As part of their year-end update filing, the company explained the entire cannabis industry faces four direct obstacles including a scarcity of experts as more markets open up to the growing market.

“Many cannabis entrepreneurs do not have access to the capital required to build the infrastructure required to meet growing demand and sales projections. Traditional sources of financing, such as banks, are not available currently to cannabis producers and retailers,” AmeriCann said.

Arena Pharmaceuticals (NASDAQ:ARNA)

Arena is a traditional biopharmaceutical company working on their pipeline of drug products. However, their APD371 candidate is an orally available product harnessing the cannabinoid-2 receptor seeking to treat visceral pain, directly associated with Crohn’s disease.

As part of their third-quarter results from 2017, the company updated shareholders on the progress of APD371. This program is currently in the phase two stage of development, the company is expecting data from this program in the first quarter of 2018.

Aphria (OTC:APHQF)

Aphria is a Canadian licensed producer (LP) with a current growing capacity of 9,000 kilograms of cannabis product per year, according to their most recent quarterly report, that number is expected to go up with the company’s planned expansions. This year Aphria made the decision to let go of its US assets, including a stake in a company based in Arizona. Aphria is engaged in the process of dropping their stake in Liberty Health Sciences, its US partner.

“While I continue to believe there is tremendous opportunity in the U.S. for medical cannabis, the sale of these shares serve the best interests of our shareholders and provide additional and important capital to fund Aphria’s continued growth in Canada and expand into other federally legal international markets,” Vic Neufeld, CEO of the company said as part of the announcement for their sale of shares in Liberty Health.

Aurora Cannabis (OTC:ACBFF)

Aurora is another Canadian LP working on their strategy in that country. Their proposed Aurora Sky facility, which will produce 100,000 kilograms of cannabis per year, received a cultivation license certification from Health Canada, the government’s regulator, in January.

“The additional cultivation capacity will allow us to further expand our domestic and international market share very quickly, and is expected to significantly accelerate revenue growth this year,” Terry Booth, CEO of the company said in their announcement.

Beleave (OTC:BLEVF)

Beleave’s subsidiary earned a cultivation license from Health Canada in June 2017. This year the company received an additional license from Health Canada to start the commercial production of cannabis oils.

“The company has put a lot of time and effort into researching various extraction techniques and is looking forward to putting this knowledge to good use,” Beleave CEO Andrew Wnek said.

Choom Holdings (OTCQB:CHOOF)

Choom is a Canadian cannabis company with a focus on the retail side of the industry. The company plans to present consumers with the option of products that appeal to the lifestyle aspect of consuming marijuana. The company has been expanding its production with recent acquisitions.

In January the company revealed the concept design for its proposed retail dispensary strategy. “As the Canadian market approaches a new cannabis recreation marketplace, meeting consumer perception and choice with social credibility will be key,” Chris Bogart, president and CEO of Choom said.

Canada House Wellness Group (OTC:SARSF)

This company is working as an operator of other cannabis operations, their goal is to develop strategic partnerships, mergers, and acquisitions. The company earned some market recognition by being added to the list of ventures available to shareholderson the Emerging Marijuana Growers Fund.

“For the benefit of all our shareholders, we’re very pleased to have been included within this ETF, for it should bring more professional investor attention to the fine work our team has been doing to enhance the operations of our three divisions,” Larry Bortles, CEO, and chairman of the company said. “As each of our verticals achieve profitability this year, we look forward to becoming a major contributor to the growth of this ETF.”

CannaRoyalty (OTC:CNNRF)

CannaRoyalty is focused on the operation and management of several cannabis businesses in the US. Their strategy is to create a portfolio of cannabis assets in states where it is legal to sell the product. The company regularly updates shareholders on new deals and tracking its engagement with cannabis ventures in legal states.

After a staff notice from the Canadian Securities Administrators was sent, requiring for cannabis companies operating in the US but publicly traded in Canada, to add an extra disclosure of risks to investors, Marc Lusting CEO of CannaRoyalty commended the move by the regulators.

“The Notice clarifies the regulatory landscape for investors and is favorable for issuers with US cannabis assets,” he said.

CannTrust Holdings (OTC:CNTTF)

CannTrust operates a 50,000 square hydroponic facility in Ontario, under the approval of its LP status. The company is working on a phase 2 expansion to its facility, expected to be completed in mid-2018. CannTrust obtained sales license from Health Canada for its facility in February.

“The expansion of our Greenhouse Facility together with our Health Canada Sales Licence will allow CannTrust to meet growing market demand and provide maximum value to our customers, partners and shareholders,” Eric Paul, CEO of the company said in a statement.

Canopy Growth (OTC:TWMJF)

Canopy is one of the biggest Canadian LPs. The Canadian behemoth earned praise from the industry by brokering a new type of deal last year when alcohol producer Constellation Brands (NYSE:STZ) invested $245 million for 9.9 percent equity of Canopy.

According to their most recent quarterly update, the company announced its recorded revenue had increased to 21.7 million, representing a 123 percent year-over-year revenue growth.

Cronos Group (NASDAQ:CRON)

Cronos is a company that has been targeting a global reach for its products. Their presence recently increased thanks to a new venture in Australia. Cronos Australia officially launched in February 2018. According to the company, this option could expand to reach in markets in New Zealand and Southeast Asia.

“I think what we’ve seen in the market is an increased rate of voices and momentum around medicinal cannabis access for patients beyond those two patient groups,” Rodney Cocks, CEO, and director of the new Australian venture said during an investor call from Cronos.

The company officially joined the Nasdaq this year, launching a movement of other cannabis companies evaluating the possibility to list in this exchange.

Emerald Health Therapeutics (OTC:EMHTF)

Emerald Health oversees a variety of arms for the company with different areas of focus, its subsidiary with an LP status, currently operates out of an indoor facility in B.C., however, the company is working on a 500,000 square feet greenhouse facility in Vancouver.

In January the company announced a partnership with DMG Blockchain Solutions to investigate the use of blockchain supply management systems for the cannabis industry, through an entirely new company, CannaChain Technologies.

“There are notable new applications of blockchain technology to validate and assure the source, quality, and integrity of products such as diamonds, wine, and art, along with coffee and other food products,” Avtar Dhillon executive chairman of Emerald Health Therapeutics said in their statement.

GW Pharmaceuticals (NASDAQ:GWPH)

GW is another traditional pharma company trading on the NASDAQ exchange. One of their main areas of focus is the treatment epilepsy conditions with their lead cannabinoid product candidate, Epidiolex. GW is currently evaluating this candidate against Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis and infantile spasms.

In December of 2017, the company announced it had been accepted for its New Drug Application (NDA) application for Epidiolex with the U.S. Food and Drug Administration (FDA).

iAnthus Capital Holdings (OTCQB:ITHUF)

iAnthus is another operator looking for companies in the US market. Their most recent area of focus is Florida, thanks to a substantial acquisition in the state. The company bought the assets of GrowHealthy Holdings.

“The GrowHealthy cultivation and operations team has already established itself as a leader in Florida’s medical cannabis market, and we look forward to contributing iAnthus’ capital and operational resources to fully build out GrowHealthy’s infrastructure,” Randy Maslow, president of iAnthus said in the announcement said.

Innovative Industrial Properties (NYSE:IIPR)

This company’s focus on cannabis comes through the acquisition of industrial real estate assets for the growth of medical cannabis. “Concurrently with our acquisition of these properties, we enter into leases with the state-licensed growers under long-term, triple-net lease agreements,” the company said.

As part of their third quarter financial results, the company announced detailed updates for facilities it held in Maryland, New York, and Minnesota. They also revealed there was an ongoing review for $100 million worth of new potential properties.

Insys Therapeutics (NASDAQ:INSY)

Their work with cannabis relates to the development of pharmaceutical cannabinoids. Their pipeline in this area currently holds two candidates involved in a variety of trials. The most advanced includes treatments for childhood absence epilepsy and infantile spasm through a cannabidiol oral solution.

During the month of December 2017, the company provided two updates for their cannabinoids programs. First, Insys announced the start of its phase 2 clinical study for their CBD oral solution against childhood absence epilepsy. The company then announced the FDA had granted it a Fast Track designation for their Prader-Willi syndrome treatment. Insys plans to start the clinical development program for this candidate in their 2018 first quarter.

Intec Pharma (NASDAQ:NTEC)

Intec completed a phase 1 clinical trial of their Accordion Pill platform in combination with CBD and tetrahydrocannabinol (THC). “The study results showed that AP-CBD/THC had significant improvements in exposure of CBD (290 percent – 330 percent) and THC (25 percent – 50 percent) compared with Sativex,” the company explained.

In January the company announced it had obtained a Canadian patent for their Accordion Pill.

Invictus MD (OTC:IVITF)

Invictus is Canadian producer involved with a variety of ventures to increase their reach in the cannabis industry. In February the company provided shareholders with an update and a closer look at its phase 2 facility expansion.

“Both the Phase 1 and Phase 2 facilities at Acreage Pharms, located in west-central Alberta, have a total of approximately 40,000 square feet with expected 5,000 kilograms of capacity beginning in February 2018, along with a further planned 80,000 square foot Phase 3 expansion for total combined production capacity of 19,000 kilograms in 2018,” the company revealed in their announcement.

Isodiol International (OTC:ISOLF)

Isodiol is a company working in the manufacturing and development of CBD consumer products. The company received a regulatory approval for their candidate Isodiolex treating epilepsy and Parkinson’s disease, by the Brazilian Health Regulatory Agency (ANVISA).

“We have been working towards additional products for the Brazilian medical community and for the last several months, so to have our second product medically approved by ANVISA is a tremendous breakthrough for the company,” Marcos Agramont, CEO of Isodiol said of the approval.

Kush Bottles (OTC:KSHB)

Kush Bottles is a company based in California working as an ancillary operation alongside the growth of the cannabis industry itself. While holding no direct contact with the actual plant itself, Kush sells packaging supplies for dispensaries and other businesses. Their expansion since launch has allowed them to sell accessories as well as develop their own brand of products.

In one of its most recent announcements, Kush Bottles shared with investors it was picked by Future Farm Technologies (CSE:FFT; OTCQB:FFRMF) to develop them a customized “packaging and comprehensive compliance solutions.”

Lexaria Bioscience (OTCQX:LXRP)

Lexaria is a company focused on enhancing the flavor, bouquet gastrointestinal delivery of edible cannabinoid consumer products. This year the company started trading on the OTCQX Best Market.

Most recently, on January 25, the company announced a partnership with Cannfections Group, a cannabis chocolate manufacturer, in which Lexaria provided their DehydraTECH for the development of “next-generation performance in cannabis-infused chocolates and candies.”

MYM Neutraceuticals (OTC:MYMMF)

MYM Nutraceuticals is focused on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products. Recently the company was part of a Deloitte report, “Economic Impact Assessment for the Weedon Project,” evaluating the benefits of the Wheedon Project in Quebec and Canada.

“We are in the final stages of lining up financing and making the necessary plans to break ground in Weedon to start building one of the world’s largest greenhouse facilities,” Rob Gietl, CEO of MYM said as part of the announcement.

Namaste Technologies (OTC:NXTTF)

Namaste is a company offering consumers an entirely new platform where they can access and purchase vaporizer products from official manufacturers, and if allowed by the country medical cannabis. In Canada, the company has signed deals with licensed producers (LPs) to offer their products in the NamasteMD app. Through the mobile application, patients can obtain a prescription for medical marijuana.

Sean Dollinger, president, and CEO of Namaste told INN the company plans to launch a smartwatch app that will be able to collect data from the users after consuming cannabis products.

Phivida Holdings (OTC:PHVAF)

Phivida works on a brand of CBD infused functional foods and beverages and clinical CBD products. The company updated shareholders on the production capabilities for their rollout of products in the California market. Among these products is their recently revealed Nano-CBD Iced Teas.

“Phivida’s Nano-CBD Iced Tea blends are designed to treat the GI-tract, and maximize the body’s ability to absorb orally ingested cannabinoids and phyto-nutraceuticals,” the company indicated.

Zynerba Pharmaceuticals (NASDAQ:ZYNE)

Zynerba is a specialty pharma company working on pharmaceutically-produced transdermal cannabinoid treatments. Their pipeline of candidates holds two cannabis-related products in various trials for different diseases like Fragile X Syndrome and Tourette Syndrome.

As part of an update to shareholders on their 2018 goals, the company announced it would refocus on rare neurological and psychiatric disorders. The company was encouraged by the data from the recent ZYN002 clinical data it obtained.

“We plan to initiate a pivotal study for ZYN002 in FXS that should read out in 2019, initiate two new Phase 2 studies in refractory epilepsies, and initiate a Phase 2 program with ZYN001 in Tourette Syndrome,” Armando Anido, Zynerba’s chairman and CEO.

Source: https://investingnews.com/daily/resource-investing/agriculture-investing/cannabis-investing/american-cannabis-stocks/

 

Tags: , , ,

Important Links

Sponsored Message

View Rate Card